Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
| Data(s) |
01/11/2006
|
|---|---|
| Resumo |
Midgut carcinoid tumours are uncommon tumours with an unpredictable clinical behaviour and few useful prognostic markers. Somatostatin analogues are widely used in treatment but a survival advantage has not been proven. We analysed features associated with poor prognosis and assessed the clinical implications of the biochemical response to therapy. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Turner , G B , Johnston , B T , McCance , D R , McGinty , A , Watson , R G P , Patterson , C C & Ardill , J E S 2006 , ' Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours ' Gut , vol 55 , no. 11 , pp. 1586-91 . DOI: 10.1136/gut.2006.092320 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2715 #Gastroenterology |
| Tipo |
article |
